Show simple item record

dc.contributor.authorCincotta, Melissa
dc.contributor.authorWanits, Lyndsey
dc.contributor.authorWhittaker, Jeremy
dc.date.accessioned2017-05-03T18:28:48Z
dc.date.available2017-05-03T18:28:48Z
dc.date.issued2017
dc.identifier.urihttp://hdl.handle.net/1951/69154
dc.descriptionColorectal Adenocarcinoma is a cancer isolated in the colon and rectum. It is the third most commonly diagnosed cancer in the United States[14].This cancer does not occur suddenly as it takes years to develop and tends to be caused by changes to the lining of the colon or rectum [4]. The p53 protein, that regulates the cell cycle to prevent mutations, is most commonly effected by colorectal adenocarcinoma by causing mismatch DNA repair sequence. [3]en_US
dc.language.isoen_USen_US
dc.titleReview of The Use of 5-Fluorouracil as a Chemotherapy Drug to Treat Colorectal Adenocarcinomaen_US
dc.typeLearning Objecten_US
dc.typePresentationen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record